ePharma Physician® Research Study and Advisory Service Focused on Physician IT Adoption

Manhattan ResearchePharma Physician® is a syndicated multi-client research study and advisory service focused on physician information technology adoption. Specifically, the study examines how technology is levered by pharmaceutical, biotech, and device companies to improve relationships with physicians. Fielded annually, ePharma Physician® builds upon Manhattan Research's population-level physician research Taking the Pulse® and probes deeper into the audience of physicians interacting with pharmaceutical, device, and biotech companies online, currently about 80% of the physician population.

The study identifies and analyzes key attitudes, behaviors and psychographics of physicians who actively use online pharmaceutical services in order to help our clients better understand this key audience and meet its market demands.

Manhattan Research approach to ePharma Physician® is based on the belief that web log data alone cannot provide a full and representative picture of who visits web properties, why they go, or their subsequent actions taken. ePharma Physician® uses an online survey and recall methodology to offer the best means for understanding, benchmarking and measuring website effectiveness.

The ePharma Physician® strategic advisory service includes:

  • A comprehensive breakdown of physician satisfaction with top branded Rx product websites and top pharmaceutical and biotech corporate websites.
  • An analysis of growing physician demand for services such as customer service portals, live remote rep interactions, and closed-loop promotional integration.
  • Additional topics such as electronic detailing use and satisfaction; top blogs, podcasts, and specialty websites visited; and opinions regarding technology enabled sales reps (i.e., tablet PC use).

Better understand the audience of online physicians through ePharma Physician® and Manhattan Research.

For further information, please visit: http://www.manhattanresearch.com/products/Strategic_Advisory/ePP/default.aspx

About Manhattan Research
In addition to ePharma Physician®, Manhattan Research conducts numerous research studies among physicians and consumers in the United States and in Europe. Each study serves a unique purpose and focuses on different aspects of information technology adoption. Broad research is complemented by targeted analysis among more than 50 consumer therapeutic segments and 25 physician specialist segments. For further information, please visit www.manhattanresearch.com

Most Popular Now

Pfizer's elranatamab granted FDA Breakthrough Ther…

Pfizer Inc. (NYSE:PFE) announced its investigational cancer immunotherapy, elranatamab, received Breakthrough Therapy Designation from the U.S. Food and Drug Administrati...

Salvat Laboratories announces submission of New Dr…

Salvat Laboratories announced that it has submitted a New Drug Application (NDA) to the FDA for the approval of the first ocular corticosteroid formulated in a nanoemulsi...

Bayer with continued strong performance

The Bayer Group maintained its strong business performance across all three divisions in the third quarter. "Despite rising inflation and global supply chain problems, we...

Vividion Therapeutics names Jenna Goldberg as Chie…

Vividion Therapeutics, Inc., a biopharmaceutical company utilizing novel discovery technologies to unlock high value, traditionally undruggable targets with precision the...

New insights on antibody responses to Omicron vari…

Knowing how well vaccination against one SARS-CoV-2 strain (with or without previous infection) counteracts infection with a different strain is a critical research quest...

Pfizer and BioNTech receive positive CHMP opinion …

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced a booster dose of their Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine (COMIRNATY® Original/Omicron ...

Sugar molecules as a target in cancer therapy

Cancer cells use sugar molecules on their surface to disable attacks by the body's immune system. Researchers at the University of Basel now report on how this mechanism ...

COVID vaccination improves effectiveness of cancer…

Patients with nasopharyngeal cancer are often treated with drugs that activate their immune system against the tumor. Until now, it was feared that vaccination against Co...

Making melanoma immortal: Pitt scientists discover…

Scientists at the University of Pittsburgh School of Medicine have discovered the missing puzzle piece in the mystery of how melanoma tumors control their mortality. I...

New drug shows promise for fighting both COVID-19 …

While vaccination can provide life-saving protection against COVID-19, scientists are still searching for ways to treat severe infections, including in people who cannot ...

Study reveals vaccine confidence declined consider…

A new study suggests that, despite the success of the COVID-19 vaccination campaigns, vaccine confidence has declined significantly since the start of the pandemic. Re...

Sanofi and GSK's next-generation COVID-19 booster …

After the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for VidPrevtyn® Beta, the vaccine was approved by t...